ArticleScientific reports2026
Deep learning-based identification of N6-methyladenine sites via hybrid feature fusion and SHAP-driven feature selection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N6-methyladenine (6 mA) is a critical epigenetic modification involved in gene regulation, genome stability, and cellular adaptation. Accurate computational identification of 6 mA sites is essential for elucidating epigenetic mechanisms and advancing disease-related research. However, existing methods are often constrained by limited feature representations and poor interpretability, hindering predictive performance and generalisation across diverse genomic contexts. To address these challenges, we propose a novel deep neural network (DNN)-based framework that integrates optimal hybrid features for robust and interpretable 6 mA site identification. The proposed framework employs a comprehensive multi-feature extraction strategy to capture complex sequence-level patterns in DNA, which are subsequently fused into a unified hybrid representation. To enhance model efficiency and interpretability, SHapley Additive exPlanations (SHAP) are applied for feature importance analysis, enabling the selection of the most discriminative features for downstream classification. The optimised feature set is then fed into a DNN classifier for accurate 6 mA site prediction. Evaluated using 5-fold cross-validation, the proposed model achieved training accuracies of 97.95% and 96.15% on the F. vesca and R. chinensis datasets, respectively. On independent test datasets, the model achieved accuracies of 97.10% (F. vesca) and 95.32% (R. chinensis), demonstrating strong generalisation. These results establish the proposed framework as an accurate, reliable, and interpretable computational tool for genome-wide identification of 6 mA sites, with broad applicability to epigenetic research and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.